I M M U N E T O L E R A N C E I N D U C T I O N S T U D Y
Welcome to the International Immune Tolerance Study Home Page.
The Study opened for recruitment late in 2002, after a delay due to the shortage of recombinant factor VIII.
The study compares the efficacy, morbidity and cost effectiveness of low versus high-dose
immune tolerance in good-risk patients.
These patients have severe haemophilia A, an inhibitor for 12 months or less and a historical peak inhibitor titre of >
5BU but < 200 units.
The electronic case report form (eCRF) used in the study requires Internet Explorer V4.1 or later.
Protocol Introduction
Study Objectives and Hypothesis
Contact Information
Posters, latest newsletter and minutes from last meeting
How to join the study
120 Patients recruited into the study
The next Investigator meeting will be held during the ASH conference in San Francisco
Sunday 7th December 12:00 - 13:30
Four Seasons Hotel (Yerba Buena Room)
757 Market Street
San Francisco, California 94103
A buffet lunch will be provided
A meeting for the RESIST protocol will follow from 13:30 to 15:00
Enter Electronic C.R.F.
Please read the
security information for Internet Explorer V5.0 or later
CMMC Users Click Here
Please read the
security information for Internet Explorer V5.0 or later
Web pages developed by: Dr R.A.Hollingsworth